Obesity-associated NLRC4 inflammasome activation drives breast cancer progression
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Obesity is associated with an increased risk of developing breast cancer and is also associated with worse clinical prognosis. The mechanistic link between obesity and breast cancer progression remains unclear, and there has been no development of specific treatments to improve the outcome of obese cancer patients. Here we show that obesity-associated NLRC4 inflammasome activation/ interleukin (IL)-1 signalling promotes breast cancer progression. The tumour microenvironment in the context of obesity induces an increase in tumour-infiltrating myeloid cells with an activated NLRC4 inflammasome that in turn activates IL-1β, which drives disease progression through adipocyte-mediated vascular endothelial growth factor A (VEGFA) expression and angiogenesis. Further studies show that treatment of mice with metformin inhibits obesity-associated tumour progression associated with a marked decrease in angiogenesis. This report provides a causal mechanism by which obesity promotes breast cancer progression and lays out a foundation to block NLRC4 inflammasome activation or IL-1β signalling transduction that may be useful for the treatment of obese cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In those cases, IL-1β is the key player, acting as pro-inflammatory, tumor-promoting trigger [126,127,128,129,130].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [129]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zaafar, D. K., Zaitone, S. A., & Moustafa, Y. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100562 · Cited by 74 · cited 1×
“This is consistent with previous studies that have shown that metformin lowers serum VEGFA levels in both human and mouse 39,40 .”
RetractedObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Whether obesity has an impact on these diseases through enhancement of inflammation or via a direct mechanism is largely unclear; however, obese adipose tissue is a reservoir for macrophages with activated inflammasomes that contribute to insulin resistance and diabetes 10,11 .”
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 1×
“Metformin is known to have pleiotropic effects, and is thought to primarily work by inhibiting mitochondrial respiratory-chain complex-I, which leads to activation of adenosine monophosphate-activated protein kinase 38 .”
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664 · cited 1×
“We We did observe a significant increase in the number of tumour-infiltrating macrophages (F4/80 þ CD11b þ ); in particular, there was a significant increase in CD11c (cid:2) macrophages and a trend for increased CD11c þ macrophages 21 (Fig.”
Györffy, B., Lanczky, A., Eklund, A. C., Denkert, C., Budczies, J., Li, Q., & Szallasi, Z. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0674-9 · Cited by 4,169 · cited 2×
“In addition, KMPlot (http://kmplot.com/analysis/) was used to analyse microarray data sets that were normalized and combined for survival analysis 41 .”
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“Metformin, a type 2 diabetes drug, reduces the risk of several types of cancer including breast cancer 35–37 .”
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Cited by
Items 201–247 of 247
The potential of the NLRC4 Inflammasome as a Cancer biomarker: A Pan-cancer investigation
Das, S., Bhattacharyya, D., Arshad, M., & Mal, C. (2024) · Human Gene · doi:10.1016/j.humgen.2024.201351 · Cited by 4
Immune dysregulation in chronic diabetic wounds: therapeutic opportunities for healing reprogramming
Yu, W., Li, Q., Wang, J., Fu, J., Hao, Y., Wang, Z., Xu, H., Zhang, M., Zhao, G., & Ma, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1889465 · Cited by 3
Metformin as target metabolic drug in oncology
Shatova, O. P., Kaplun, D., & Zinkovych, I. (2017) · Malignant tumours · doi:10.18027/2224-5057-2017-2-83-89 · Cited by 2
Targeting adipocyte–immune cell crosstalk to control breast cancer progression
Wang, W., Chen, H., Yin, S., Yang, Z., & Zhang, F. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04685-3 · Cited by 2
“The secreted IL-1β upregulates VEGF expression in adipocytes and leads to resistance to anti-VEGF therapy in breast cancer (Kolb et al. 2016).”
BackgroundWeighted Gene Co-expression Network Analysis of Gene Modules for Lung Adenocarcinoma
Zhai, Y., Chen, Y., Jiang, Y., & Li, Q. (2018) · International Conference on Systems and Informatics (ICSAI) · doi:10.1109/icsai.2018.8599411 · Cited by 2
Conner, S. J., Guarin, J. R., Borges, H. B., Salhany, K. J., Mensah, D. N., Hamilton, G. A., Le, G. H., & Oudin, M. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.24.554492 · Cited by 2
“In murine models of diet-induced obesity (DIO) and breast cancer, HFD has been shown to promote primary tumor growth [25]–[30], lung metastasis [25], [26], [29], [31], and liver metastasis [31].”
BackgroundMolecular regulation of NAIP/NLRC4 inflammasomes
Amaral, M. P., Branco, L. M., Lage, S. L., & Bortoluci, K. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00016-5 · Cited by 1
Ammendola, M., Vescio, F., Rotondo, C., Arturi, F., Luposella, M., Zuccalà, V., Battaglia, C., Laganà, D., Ranieri, G., Navarra, G., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13154434 · Cited by 1
Xu, Z., Xue, M., Yang, Y., Xu, X., Wang, X., Wang, M., Liu, T., Liu, Z., Yuan, H., Zhang, W., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145149 · Cited by 1
Self-citationBrain-cancer interactions outside the CNS
Li, W., Huo, R., Liu, S., He, K., Wu, H., Wang, H., Jiang, S., & Xue, J. (2026) · Oncogene · doi:10.1038/s41388-026-03684-1 · Cited by 1
Self-citationIL-1-driven systemic inflammation in tumour progression and metastatic spread
Alford, J., & Garner, H. (2026) · Seminars in Immunology · doi:10.1016/j.smim.2026.102052 · Cited by 1
Role of the Inflammasome in Cancer
Terlizzi, M., Colarusso, C., Pinto, A., & Sorrentino, R. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_15 · Cited by 1
Chronic periodontitis as a risk factor for breast cancer: An update
Modak, B., Basu, A., Roychowdhury, D., & Saha, A. (2020) · International Journal of Applied Dental Sciences · doi:10.22271/oral.2020.v6.i3k.1028 · Cited by 1
“[11] also reported that Inflammasomes mediate the expression of adipocyte-mediated vascular endothelial growth factor A (VEGF-A), and accelerates the progression of breast cancer.”
BackgroundRébé, C., Perrichet, A., & Ghiringhelli, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91802-2.00009-8 · Cited by 1
Dong, C., Zhang, Q.-H., Zhang, Y., Zhang, Y., Ruan, H., Qin, T., Zhao, J.-H., Wu, G., Zhu, Z., & Yang, J. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106622 · Cited by 1
Obesity Promotes the Ceramide-Mediated NADPH Oxidase in Acute Myeloid Leukemia.
Wang, W., Sabol, R. J., Day, A. M., Hathorn, T. G., Clark, M. N., Connell, S. E., Mantis, E. A., Traore, M., Siciliano, J. M., Arsenault, E. J., et al. (2024) · PubMed · Cited by 1
Role of Inflammation and Inflammasomes in Bone Pathophysiology
Mbalaviele, G., & Abu‐Amer, Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11167-5 · Cited by 1
Hidrogenación catalítica de aceites vegetales
Gutiérrez-Ortiz, J. I., González, C. A. L., & González-Velasco, J. R. (1997) · Alimentación, equipos y tecnología · Cited by 2
Vastrad, B. M., & Vastrad, C. M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.10.579759 · Cited by 1
Collagen and fibronectin: threads linking obesity and breast cancer
Ellies, L. G. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.10.11 · Cited by 1
“Metformin inhibited obesity-associated tumor progression and was associated with a marked reduction in angiogenesis (16).”
BackgroundSelf-citationMECHANISM OF NEUTROPHIL HOMEOSTASIS AND IMMUNITY IN PNEUMONIA AND SEPSIS
Paudel, S. (2019) · Louisiana State University · doi:10.31390/gradschool_dissertations.5064
Mecanismos moleculares envolvidos na ativação do inflamassoma NAIP/NLRC4
Branco, L. M. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2019.tde-16122019-120656
The interconnection between the inflammasome and breast cancer
Balahura, L.-R., Dinescu, S., & Costache, M. (2020) · Reviews in Biological and Biomedical Sciences · doi:10.31178/rbbs.2020.3.1.3
Fernandes, F. P. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2020.tde-01072021-115731
Dawson, R., & Jenkins, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85563-1.00007-1
Big data analytics and cancer biology: lessons in taking science from the processor to the patient
Borcherding, N. C., Zhan, F., Tanas, M. R., Weigel, R. J., Zhang, W., & Dupuy, A. J. (2020) · doi:10.17077/etd.005280
Self-citationLopes, L. D. S. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2022.tde-08112022-173318
Mouse Models of Obesity to Study the Tumor-Immune Microenvironment
Petrecca, S., & Quail, D. F. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2914-7_9
Identificação de novas proteínas envolvidas na ativação do inflamassoma de NLRC4
Becerra, A. D. M. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2022.tde-03012023-113847
Role of inflammasomes NLRC4 in pathogenesis of leprosy
Batta, S. M. A., Elfar, N. N., Soliman, N. A., & Nassar, S. O. (2023) · International Journal of Dermatology Venereology and Leprosy Sciences · doi:10.33545/26649411.2023.v6.i1b.135
“Obese individuals with breast cancer were found to have an activated NLRC4, but not an NLRP3, inflammasome ([47]).”
BackgroundHu, C., Chen, X., Yao, C., Liu, Y., Xu, H., Zhou, G., Xia, H., & Xia, J. (2020) · Figshare · doi:10.6084/m9.figshare.13010774
Self-citationHu, J., Tian, C., Zhao, Y., Guo, Y., & Chen, S. (2022) · Figshare · doi:10.6084/m9.figshare.20315798
Hu, C., Chen, X., Yao, C., Liu, Y., Xu, H., Zhou, G., Xia, H., & Xia, J. (2020) · Figshare · doi:10.6084/m9.figshare.13010771
Self-citationHu, C., Chen, X., Yao, C., Liu, Y., Xu, H., Zhou, G., Xia, H., & Xia, J. (2020) · Figshare · doi:10.6084/m9.figshare.13010777
Self-citationMészáros, Á. (2024) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.12242
Kour, A., Sambyal, V., Guleria, K., Singh, N. R., Uppal, M. S., Manjari, M., & Sudan, M. (2020) · Figshare · doi:10.6084/m9.figshare.13213201
Wu, X., Qian, S., Zhang, J., Feng, J., Luo, K., Sun, L., Zhao, L., Ran, Y., Sun, L., Wang, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14584009
Wu, X., Qian, S., Zhang, J., Feng, J., Luo, K., Sun, L., Zhao, L., Ran, Y., Sun, L., Wang, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14584012
Wu, X., Qian, S., Zhang, J., Feng, J., Luo, K., Sun, L., Zhao, L., Ran, Y., Sun, L., Wang, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14584006
Wu, X., Qian, S., Zhang, J., Feng, J., Luo, K., Sun, L., Zhao, L., Ran, Y., Sun, L., Wang, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14584003
Ciblage de l'IL-1beta pour améliorer l'efficacité de la chimio-immunothérapie dans le cancer
Perrichet, A. (2024) · theses.fr (ABES) · doi:10.70675/b9026a2bzb830z46f0z8122z216dad542b24
Tang, Y., Chen, Z., Sarkar, H., Wei, Y., Lopez-Darwin, S. L., Roichman, A., Park, J. W., Li, Q., Fang, C., Chen, Z., et al. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.08.003
Meng, J., & Bao, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1961059
“This subsequently activates IL-1 b and drives breast cancer progression by promoting adipocyte-mediated vascular expression of VEGFA and angiogenesis (96).”
Interconnected death: crosstalk among ferroptosis, cuproptosis, and pyroptosis in cancer
Liu, Y., Liu, J., Zeng, D., Chen, L., Wei, C., Qiu, X., Fu, L., & Deng, Z. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02799-z
Self-citationBaş, D. (2021) · Acibadem University Open Access Repository
Amaral, M. P., Cardoso, F. D., de Farias, I. S., de Souza, R. Q., Matteucci, K. C., Torrecilhas, A. C., & Bortoluci, K. R. (2023) · doi:10.3389/fimmu.2023.1282856.s003
Metadata
- Authors
- Kolb, R., Phan, L., Borcherding, N., Liu, Y., Yuan, F., Janowski, A. M., Xie, Q., Markan, K. R., Li, W., Potthoff, M. J., Fuentes-Mattei, E., Ellies, L. G., Knudson, C. M., Lee, M.-H., Yeung, S.-C. J., Cassel, S. L., Sutterwala, F. S., & Zhang, W.
- Affiliations
- University of Iowa (US)
- The University of Texas MD Anderson Cancer Center (US)
- Central South University (CN)
- University of California San Diego (US)
- Corresponding author
- Zhang, Weizhou
- ORCID
- Venue
- Nature Communications
- Published
- 2016-10-06
- Volume
- 7
- Issue
- 1
- Pages
- 13007-13007
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5059727
- OpenAlex
- W2529393815
- Cited by
- 239
- References
- 58
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 17 · 2023: 34 · 2022: 27 · 2021: 37 · 2020: 39 · 2019: 24 · 2018: 17 · 2017: 14 · 2016: 2
- FWCI
- 9.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (NIH T32, KG081048, NIH-R01, AI118719, CA158055)
- University of Texas Health Science Center at San Antonio
- Holden Comprehensive Cancer Center, University of Iowa (P30-CA086862)
- National Cancer Institute (K99CA158055, CA203834, R00CA158055, R01CA200673, CA200673, L30 CA199587, R01CA203834, K22CA118182, P30CA086862)
- National Institute of Allergy and Infectious Diseases (R56AI118719, T32AI007260, R01AI104706, T32AI007485, T32AI007517)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK111758)
- National Institute on Minority Health and Health Disparities (L60 MD006355)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- obesity, breast cancer progression, NLRC4 inflammasome, tumor microenvironment, VEGF-A, angiogenesis, adipocytes, metformin
- MeSH terms
- Animals, Breast, Breast Neoplasms, Calcium-Binding Proteins, Female, Humans, Mammary Neoplasms, Experimental, Mice, Inbred C57BL, Neoplasm Transplantation, Obesity, Signal Transduction, Lymphocytes, Tumor-Infiltrating, Disease Progression, Myeloid Cells, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Apoptosis Regulatory Proteins, Mice, CARD Signaling Adaptor Proteins, Interleukin-1beta, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.